BACKGROUND: Infliximab, a monoclonal antibody against tumor necrosis factor, is an effective maintenance therapy for patients with Crohn's disease without fistulas. It is not known whether infliximab is an effective maintenance therapy for patients with fistulas. METHODS: We performed a multicenter,...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!